| dbo:abstract |
Jörgen Erik Lehmann (15 January 1898 – 26 December 1989) was a Danish-born Swedish physician and chemist best known for his discovery in the 1940s that para-amino salicylic acid (PAS) would make an excellent orally-available tuberculosis therapy. PAS was, together with streptomycin, the first efficacious anti-microbial therapy for tuberculosis and remained in clinical use for several decades. In 1941, Lehmann also developed the anti-coagulant dicumarol, which is used for the prevention of blood clots and in the treatment of deep venous thrombosis. Lehmann studied under Torsten Thunberg, professor of physiology in Lund, who discovered the dehydrogenases. Lehmann was appointed professor of physiology in Aarhus in 1937, and became head of the central laboratory at the Sahlgrenska University Hospital in Gothenburg 1938. After retiring in 1963, Lehmann continued his research at the Nobel Laureate Arvid Carlsson's institution at the University of Gothenburg. Jörgen Lehmann was son of , professor of History of Religions at Lund University and grandnephew of the Danish politician Orla Lehmann. (en) Jörgen Erik Lehmann, född 15 januari 1898, död 26 december 1989, var en dansk–svensk läkare och biokemist. Lehmann var professor i Aarhus 1937–1938 och därefter chef för centrallaboratoriet vid Sahlgrenska sjukhuset i Göteborg 1938–1963. Hans upptäckter av effekten av Paraaminosalicylsyra (PAS) och streptomycin vid tuberkulos räknas som några av medicinhistoriens mest betydelsefulla genombrott. (sv) |
| dbo:award |
dbr:Björkénska_priset |
| dbo:birthDate |
1898-01-15 (xsd:date) |
| dbo:deathDate |
1989-12-26 (xsd:date) |
| dbo:knownFor |
dbr:Tuberculosis |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Lehman_1.jpg?width=300 |
| dbo:wikiPageExternalLink |
http://www.ne.se/jsp/search/article.jsp%3Fi_art_id=239258 |
| dbo:wikiPageID |
3694890 (xsd:integer) |
| dbo:wikiPageLength |
2169 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1124823481 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Björkénska_priset dbr:Blood_clots dbr:Denmark dbc:Danish_emigrants_to_Sweden dbr:University_of_Gothenburg dbr:Dehydrogenase dbr:Deep_venous_thrombosis dbc:1898_births dbr:Chemist dbc:1989_deaths dbr:Lund dbr:Lund_University dbr:Streptomycin dbr:Professor dbr:Tuberculosis dbr:Aarhus dbr:Arvid_Carlsson dbc:Members_of_the_Royal_Swedish_Academy_of_Sciences dbc:University_of_Gothenburg_alumni dbc:University_of_Gothenburg_faculty dbc:Swedish_chemists dbr:Sweden dbr:Torsten_Thunberg dbr:Physiology dbr:Orla_Lehmann dbr:Physician dbr:Sahlgrenska_University_Hospital dbr:Para-amino_salicylic_acid dbr:Anti-coagulant dbr:Dicumarol dbr:Nobel_Laureate dbr:Edvard_Lehmann_(historian) |
| dbp:awards |
Björkénska priset (en) |
| dbp:birthDate |
1898-01-15 (xsd:date) |
| dbp:deathDate |
1989-12-26 (xsd:date) |
| dbp:knownFor |
PAS tuberculosis therapy (en) |
| dbp:name |
Jörgen Lehmann (en) |
| dbp:wikiPageUsesTemplate |
dbt:Authority_control dbt:Birth_date dbt:Short_description dbt:Death_date_and_age dbt:Infobox_scientist dbt:Chemist-stub dbt:Sweden-scientist-stub |
| dcterms:subject |
dbc:Danish_emigrants_to_Sweden dbc:1898_births dbc:1989_deaths dbc:Members_of_the_Royal_Swedish_Academy_of_Sciences dbc:University_of_Gothenburg_alumni dbc:University_of_Gothenburg_faculty dbc:Swedish_chemists |
| gold:hypernym |
dbr:Physician |
| rdf:type |
owl:Thing foaf:Person dbo:Person dul:NaturalPerson wikidata:Q19088 wikidata:Q215627 wikidata:Q5 wikidata:Q729 dbo:Animal dbo:Eukaryote dbo:Scientist dbo:Species schema:Person wikidata:Q901 yago:CausalAgent100007347 yago:Chemist109913824 yago:LivingThing100004258 yago:Object100002684 yago:Organism100004475 yago:Person100007846 yago:PhysicalEntity100001930 yago:YagoLegalActor yago:YagoLegalActorGeo yago:Scientist110560637 yago:Whole100003553 yago:WikicatSwedishChemists |
| rdfs:comment |
Jörgen Erik Lehmann, född 15 januari 1898, död 26 december 1989, var en dansk–svensk läkare och biokemist. Lehmann var professor i Aarhus 1937–1938 och därefter chef för centrallaboratoriet vid Sahlgrenska sjukhuset i Göteborg 1938–1963. Hans upptäckter av effekten av Paraaminosalicylsyra (PAS) och streptomycin vid tuberkulos räknas som några av medicinhistoriens mest betydelsefulla genombrott. (sv) Jörgen Erik Lehmann (15 January 1898 – 26 December 1989) was a Danish-born Swedish physician and chemist best known for his discovery in the 1940s that para-amino salicylic acid (PAS) would make an excellent orally-available tuberculosis therapy. PAS was, together with streptomycin, the first efficacious anti-microbial therapy for tuberculosis and remained in clinical use for several decades. In 1941, Lehmann also developed the anti-coagulant dicumarol, which is used for the prevention of blood clots and in the treatment of deep venous thrombosis. (en) |
| rdfs:label |
Jörgen Lehmann (en) Jörgen Lehmann (sv) |
| owl:sameAs |
freebase:Jörgen Lehmann http://viaf.org/viaf/284972143 http://d-nb.info/gnd/1145457630 http://d-nb.info/gnd/126598584 wikidata:Jörgen Lehmann http://data.bibliotheken.nl/id/thes/p068023081 http://arz.dbpedia.org/resource/يورجن_ليمان dbpedia-da:Jörgen Lehmann dbpedia-sv:Jörgen Lehmann https://global.dbpedia.org/id/3preR |
| prov:wasDerivedFrom |
wikipedia-en:Jörgen_Lehmann?oldid=1124823481&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Lehman_1.jpg |
| foaf:isPrimaryTopicOf |
wikipedia-en:Jörgen_Lehmann |
| foaf:name |
Jörgen Lehmann (en) |
| is dbo:wikiPageDisambiguates of |
dbr:Lehmann |
| is dbo:wikiPageRedirects of |
dbr:Jorgen_Lehmann dbr:Joergen_Lehmann dbr:Jørgen_Lehmann |
| is dbo:wikiPageWikiLink of |
dbr:Björkénska_priset dbr:Deaths_in_December_1989 dbr:Jörgen_(name) dbr:4-Aminosalicylic_acid dbr:Lehmann dbr:Jorgen_Lehmann dbr:Frederick_Bernheim dbr:Joergen_Lehmann dbr:Jørgen_Lehmann |
| is foaf:primaryTopic of |
wikipedia-en:Jörgen_Lehmann |
